Plasmodium falciparum malaria

Related records

Broader conditions (12)

• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Disease of primarily extrinsic mechanism
• Erythrocyte disorder
• Hematologic disorder
• Human disease
• Infectious disease
• Malaria
• Parasitic infectious disease
• Protozoa infectious disease
• Vector-borne disease

Trials (443)

• "Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"
• A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects
• A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects
• A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates
• A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses
• A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)
• A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria
• A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
• A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607
• A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™
• A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria
• A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™
• A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI
• A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria
• A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1
• A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria
• A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5
• A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults
• A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.
• A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Approved drugs (2)

• Mefloquine hydrochloride
• Quinine sulfate

Drugs in development (48)

• Acetaminophen Phase 3
• Aluminum hydroxide Phase 1
• Aluminum phosphate Phase 1
• Amodiaquine Phase 3
• Amoxicillin Phase 3
• Arginine Phase 1
• Arginine hydrochloride Phase 2
• Artefenomel Phase 2
• Artemether Phase 3
• Artenimol Phase 3
• Arterolane Phase 2
• Artesunate Phase 3
• Atovaquone Phase 3
• Azithromycin Phase 3
• Chloroquine Phase 3
• Chlorproguanil Phase 3
• Cipargamin Phase 2
• Dapsone Phase 3
• DSM-265 Phase 2
• Fosmidomycin Phase 2